Babi Ramesh Reddy Nallamilli

Babi Ramesh Reddy Nallamilli

Auto-generated profile, based on publicly available information

Babi Ramesh Reddy Nallamilli

Revvity Omics Pittsburgh Pennsylvania USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2021 in Human Mutation
Verified
Journal Article
Closed access
PDF file
BNBabi R. R. Nallamilli
Babi R. R. Nallamilli
ACAlka Chaubey
Alka Chaubey
CVC. A. Valencia
C. A. Valencia
LSLeah Stansberry
Leah Stansberry
ABAndrea M. Behlmann
Andrea M. Behlmann
MHMadhuri Hegde
Madhuri Hegde

1 February 2014 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
AAArunkanth Ankala
Arunkanth Ankala
BNBabi R. Nallamilli
Babi R. Nallamilli
LRLaura Elaine Rufibach
Laura Elaine Rufibach
EHEsther Hwang
Esther Hwang
MHMadhuri R. Hegde
Madhuri R. Hegde

15 October 2020 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
BNBabi Ramesh Reddy Nallamilli
Babi Ramesh Reddy Nallamilli
SCSamya Chakravorty
Samya Chakravorty
AKAkanchha Kesari
Akanchha Kesari
LBLora Bean
Lora Bean
MHMadhuri Hegde
Madhuri Hegde

5 April 2024 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
ADArul J. Duraisamy
Arul J. Duraisamy
RLRuby Liu
Ruby Liu
SSShruti Sureshkumar
Shruti Sureshkumar
RRRajiv Rose
Rajiv Rose
LJLakshmanan Jagannathan
Lakshmanan Jagannathan
MHMadhuri Hegde
Madhuri Hegde

1 April 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
AKAkanchha Kesari
Akanchha Kesari
SSShruti Sureshkumar
Shruti Sureshkumar
RRRajiv Rose
Rajiv Rose
BNBabi Ramesh Reddy Nallamilli
Babi Ramesh Reddy Nallamilli
CCChristin Collins
Christin Collins
MHMadhuri Hegde
Madhuri Hegde

20 August 2026 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
SRStephanie M. Rice
Stephanie M. Rice
MMMona Makhamreh
Mona Makhamreh
SWSascha Wodoslawsky
Sascha Wodoslawsky
MTMariella Toro
Mariella Toro
ECElizabeth Critchlow
Elizabeth Critchlow
HAHuda B. Al‐Kouatly
Huda B. Al‐Kouatly
Nonimmune hydrops fetalis (NIHF) is characterized by abnormal fluid accumulation in ≥ 2 fetal compartments and may be genetic. The incremental diagnostic yield of prenatal exome sequencing (ES) for NIHF following a negative standard workup was previously explored on 22 cases. We report ES findings in the remaining cohort and investigate the incremental yield of genome sequencing (GS) in cases without a definitive diagnosis from exome. Enrollment criteria and exome methodology for the Hydrops‐Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) study were previously reported. Exomes without a definitive diagnosis were reviewed with updated clinical information and had GS if DNA was available. A genetic counselor returned the clinical reports. Overall, 50 exomes yielded 22 (44%) diagnoses and six possible diagnoses (12%). Nine new cases (9/28, 68%) had a diagnosis involving one of the following genes: RIT1, SOS1, RYR1, FLT4, LMOD2, KMT2D, PUF60, and BLTP1 . Two additional cases were diagnosed upon reclassification of uncertain variants. GS of eligible ES cases resulted in an incremental diagnostic yield of 7% (1/14). ES and GS in NIHF significantly reduce the number of unexplained cases and guide clinical management and recurrence risks. Currently, the incremental diagnostic yield of GS over ES in NIHF remains under investigation. Trial Registration: ClinicalTrials.gov identifier: NCT03911531